Home > Annual Financials > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE Financial Statement Analysis
[BOM: 532531|NSE : STAR]

The Revenues of STRIDES PHARMA SCIENCE have increased by 9.83% YoY .
The Earnings Per Share (EPS) of STRIDES PHARMA SCIENCE has decreased by Negative YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

STRIDES PHARMA SCIENCE Last 5 Annual Financial Results
[BOM: 532531|NSE : STAR]

ConsolidatedMar2024
Mar2023
Mar2022
Mar2021
Mar2020
Revenues ₹4,051 Cr₹3,688 Cr₹3,070 Cr₹3,316 Cr₹2,752 Cr
Expenses ₹3,318 Cr₹3,303 Cr₹3,092 Cr₹2,689 Cr₹2,236 Cr
Operating Profit (Excl OI) ₹733 Cr₹385 Cr₹-22 Cr₹627 Cr₹516 Cr
Other Income ₹50 Cr₹135 Cr₹133 Cr₹59 Cr₹53 Cr
Interest ₹314 Cr₹261 Cr₹177 Cr₹150 Cr₹156 Cr
Depreciation ₹221 Cr₹243 Cr₹233 Cr₹206 Cr₹174 Cr
Profit Before Tax ₹-117 Cr₹-286 Cr₹-653 Cr₹275 Cr₹55 Cr
Profit After Tax ₹-149 Cr₹-231 Cr₹-474 Cr₹244 Cr₹43 Cr
Consolidated Net Profit ₹-71 Cr₹-203 Cr₹-460 Cr₹268 Cr₹36 Cr
Earnings Per Share (Rs)₹-7.68₹-22.44₹-51.25₹29.93₹4.06
PAT Margin (%)-2.38-3.70-8.904.450.92
ROE(%)-6.88-10.15-18.499.211.68
ROCE(%)4.15-0.49-9.499.084.06
Total Debt/Equity(x)1.141.271.180.760.78

Key Financials

Market Cap : ₹ 8,045.4 Cr
Revenue (TTM) : ₹ 4,632.7 Cr
Net Profit(TTM) : ₹ 358.2 Cr
EPS (TTM) : ₹ 38.8
P/E (TTM) : 22.5

Industry Peers & Returns1W1M1Y
STRIDES PHARMA SCIENCE -1.2% 6.4% -7.5%
SUN PHARMACEUTICAL INDUSTRIES -0.7% -1.3% 6.6%
DIVIS LABORATORIES 1.8% 4.8% 49.8%
CIPLA -1.1% -1.3% -1.4%
TORRENT PHARMACEUTICALS 0.6% 4.2% 15.1%
DR REDDYS LABORATORIES -1.8% -6% -1.6%
MANKIND PHARMA 6.9% 6.2% 13.7%
ZYDUS LIFESCIENCES -2.1% -0.3% -15.4%
LUPIN -2.2% -4.7% 8.6%


STRIDES PHARMA SCIENCE Revenues
[BOM: 532531|NSE : STAR]

Y-o-Y

9.83 %

5 Yr CAGR

10.15 %

Years Revenues % Change
Mar2024 ₹4,051 Cr
9.83
Mar2023 ₹3,688 Cr
20.13
Mar2022 ₹3,070 Cr
-7.41
Mar2021 ₹3,316 Cr
20.49
Mar2020 ₹2,752 Cr -


STRIDES PHARMA SCIENCE Operating Profit
[BOM: 532531|NSE : STAR]

Y-o-Y

90.27 %

5 Yr CAGR

9.18 %

Years Operating Profit % Change
Mar2024 ₹733 Cr
90.27
Mar2023 ₹385 Cr
Positive
Mar2022 ₹-22 Cr
Negative
Mar2021 ₹627 Cr
21.50
Mar2020 ₹516 Cr -

Operating Margins
Y-o-Y

73.21 %

5 Yr CAGR

-0.88 %

Years Operating Margin% % Change
Mar2024 18.1%
73.21
Mar2023 10.45%
Positive
Mar2022 -0.7%
Negative
Mar2021 18.9%
0.80
Mar2020 18.75% -

STRIDES PHARMA SCIENCE Profit After Tax
[BOM: 532531|NSE : STAR]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years Profit After Tax % Change
Mar2024 ₹-71 Cr
Negative
Mar2023 ₹-203 Cr
Negative
Mar2022 ₹-460 Cr
Negative
Mar2021 ₹268 Cr
637.66
Mar2020 ₹36 Cr -

PAT Margins
Y-o-Y

Negative

5 Yr CAGR

Negative

Years PAT Margin(%) % Change
Mar2024 -2.38 %
Negative
Mar2023 -3.7 %
Negative
Mar2022 -8.9 %
Negative
Mar2021 4.45 %
383.70
Mar2020 0.92 % -

STRIDES PHARMA SCIENCE Earnings Per Share (EPS)
[BOM: 532531|NSE : STAR]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years EPS % Change
Mar2024 ₹-7.68
Negative
Mar2023 ₹-22
Negative
Mar2022 ₹-51
Negative
Mar2021 ₹30
637.19
Mar2020 ₹4.06 -

STRIDES PHARMA SCIENCE Return on Capital Employed (ROCE)
[BOM: 532531|NSE : STAR]

Y-o-Y

Positive

5 Yr CAGR

0.55 %

Years ROCE % Change
Mar2024 4.15%
Positive
Mar2023 -0.49%
Negative
Mar2022 -9.49%
Negative
Mar2021 9.08%
123.65
Mar2020 4.06% -

STRIDES PHARMA SCIENCE Share Price vs Sensex

Current Share Price : ₹872.6
Current MarketCap: ₹ 8,045.4 Cr
Updated EOD on :Jul 09,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE

-1.2%

6.4%

-7.5%

SENSEX

0.2%

1.3%

4.4%

STRIDES PHARMA SCIENCE related INDICES

BSE Indices1W1M1Y
BSE ALLCAP 6.4% 8.9% 7.5%
BSE MIDSMALLCAP 4.7% 9% 8.4%
BSE SMALLCAP 0.6% 1.4% 1.9%
BSE HEALTHCARE 0.5% 2.3% 17.5%
NSE Indices1W1M1Y
NIFTY MIDSMALL HEALTHCARE 0.6% 3.7% 20.6%
NIFTY MICROCAP 250 0.4% 1.1% 1.7%
NIFTY TOTAL MARKET 0.1% 1% 2.8%

You may also like the below Video Courses


FAQ about STRIDES PHARMA SCIENCE Financials


How the annual revenues of STRIDES PHARMA SCIENCE have changed ?

The Revenues of STRIDES PHARMA SCIENCE have increased by 9.83% YoY .

How the Earnings per Share (EPS) of STRIDES PHARMA SCIENCE have changed?

The Earnings Per Share (EPS) of STRIDES PHARMA SCIENCE has decreased by Negative YoY .